Jasper Therapeutics (NASDAQ:JSPR) Stock Rating Reaffirmed by HC Wainwright
HC Wainwright reiterated their buy rating on shares of Jasper Therapeutics (NASDAQ:JSPR – Free Report) in a research report released on Tuesday morning, Benzinga reports. The firm currently has a $65.00 price objective on the stock. JSPR has been the topic of a number of other reports. Cantor Fitzgerald reaffirmed an “overweight” rating on shares […]
More Stories
Century Financial (OTCMKTS:CYFL) Shares Pass Below Fifty Day Moving Average – Here’s What Happened
Century Financial Co. (OTCMKTS:CYFL – Get Free Report)’s share price crossed below its 50-day moving average during trading on Friday...
Koninklijke KPN (OTCMKTS:KKPNY) Stock Crosses Above 50-Day Moving Average – Should You Sell?
Koninklijke KPN (OTCMKTS:KKPNY – Get Free Report) shares crossed above its 50-day moving average during trading on Friday . The...
Renault (OTCMKTS:RNSDF) Stock Price Crosses Below 50-Day Moving Average – Should You Sell?
Renault SA (OTCMKTS:RNSDF – Get Free Report)’s share price crossed below its 50 day moving average during trading on Friday...
Ellsworth Advisors LLC Boosts Holdings in iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH)
Ellsworth Advisors LLC raised its holdings in iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH – Free Report) by 40.7% during the...
Insider Selling: nCino, Inc. (NASDAQ:NCNO) Insider Sells $1,043,100.00 in Stock
nCino, Inc. (NASDAQ:NCNO – Get Free Report) insider Sean Desmond sold 30,000 shares of the company’s stock in a transaction...
Morgan Stanley Trims UnitedHealth Group (NYSE:UNH) Target Price to $610.00
UnitedHealth Group (NYSE:UNH – Free Report) had its price objective cut by Morgan Stanley from $615.00 to $610.00 in a...